Longevity and Cellular Aging Research
Preclinical investigation of compounds studied for telomere biology, mitochondrial aging, sirtuin signaling, and cellular lifespan extension in rodent and in vitro models.
Research Overview
Longevity and cellular aging research encompasses the preclinical investigation of biological hallmarks associated with the aging process, including telomere attrition, mitochondrial dysfunction, cellular senescence, and epigenetic drift. Compounds studied in this domain have been examined in models ranging from isolated somatic cell cultures to aged rodent cohorts. Khavinson et al. documented telomerase activation and extended replicative lifespan in human fetal fibroblasts treated with Epithalon across a series of in vitro studies published between 2003 and 2012. NAD+ precursor research in aged C57BL/6 mice, including studies from the Sinclair laboratory at Harvard, documented restoration of mitochondrial function, improved vascular density in skeletal muscle, and enhanced exercise endurance in aging murine subjects. MOTS-c studies in C. elegans and aged murine models documented AMPK pathway upregulation and extended mean lifespan under metabolic stress conditions. The organizing framework for this research domain is the hallmarks of aging model described by Lopez-Otin and colleagues in Cell (2013), which provides the theoretical structure for identifying and prioritizing molecular targets relevant to biological aging.
Key Research Findings
Findings from preclinical in vitro and in vivo model systems. All summaries reference published research models.
Lifespan Extension in Rodent and In Vitro Models
Khavinson et al. documented extended replicative capacity and telomere elongation in Epithalon-treated human fetal fibroblasts in vitro, with additional lifespan studies in Wistar rats and Drosophila models showing increased mean and maximum lifespan relative to untreated controls. Separate rodent studies in aging SHR and CBA mice reported reduced tumor incidence and extended survival in Epithalon-treated cohorts compared to vehicle-treated controls.
Mitochondrial Function in Aged Murine Subjects
Studies from the Sinclair laboratory (Das et al., Cell, 2018) documented that NAD+ precursor supplementation in aged C57BL/6 mice restored capillary density in skeletal muscle, improved mitochondrial function measured by oxygen consumption rate, and enhanced exercise endurance compared to vehicle-treated aged controls. The proposed mechanism involved SIRT1 deacetylase activation and restoration of VEGF-HIF-1alpha signaling in muscle vasculature of aging murine subjects.
AMPK Activation by Mitochondrial-Derived Peptides in Aging Models
Lee et al. (Cell Metabolism, 2015) documented that MOTS-c, a peptide encoded in the mitochondrial 12S rRNA gene, activated AMPK via an AICAR-related pathway in murine skeletal muscle and extended lifespan in aging C57BL/6 mice treated with daily MOTS-c injections. The study further documented improved glucose tolerance and reduced adiposity in aged murine subjects compared to saline-treated age-matched controls.
Copper Peptide Gene Modulation Across Aging Pathways
Pickart and Margolina published large-scale transcriptomics data documenting that GHK-Cu modulated expression of more than 4,000 genes in human cell cultures, including upregulation of antioxidant defense pathways, collagen synthesis genes, and genes associated with DNA repair and mitochondrial function. Separate wound healing studies in aged murine models documented accelerated tissue repair and improved collagen organization in GHK-Cu-treated animals compared to untreated aged controls.
Compounds Studied in This Area
Research compounds with documented preclinical activity in this domain.
Broader Research Context
The cellular aging research field has expanded substantially since identification of conserved aging pathways including mTOR, AMPK, sirtuin, and telomere biology axes across model organisms from C. elegans and Drosophila to murine and primate systems. Multi-hallmark frameworks for organizing longevity research provide a systematic approach to studying compounds that target distinct aging mechanisms. Preclinical evidence from rodent aging models and in vitro systems forms the primary evidence base for longevity-focused research compounds, with convergent findings across multiple independent research groups strengthening the mechanistic case for further investigation.
Research Questions
Continue Your Research
Browse all research areas or explore the full Research Library for compound comparisons, study indexes, and use case guides.